BENGALURU, April 20 — Johnson & Johnson said today it has submitted an application to India's drug regulator requesting approval to conduct a bridging clinical study of its single-dose Covid-19 vaccine in the country.
Last week, India said it would fast-track emergency approvals for foreign-made Covid-19 vaccines, in a move that would exempt companies from carrying out local safety trials for their vaccines. — Reuters
